# Comparison of Intranasal Oxytocin Effects Using Co-administration With a Vasoconstrictor

> **NCT04134663** · NA · COMPLETED · sponsor: **University of Electronic Science and Technology of China** · enrollment: 96 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** vasoconstrictor and oxytocin treatment
- **DRUG:** vasoconstrictor's placebo and oxytocin treatment
- **DRUG:** vasoconstrictor and oxytocin's placebo treatment

## Key facts

- **NCT ID:** NCT04134663
- **Lead sponsor:** University of Electronic Science and Technology of China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-02
- **Primary completion:** 2021-06-18
- **Final completion:** 2021-07-20
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2022-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04134663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04134663, "Comparison of Intranasal Oxytocin Effects Using Co-administration With a Vasoconstrictor". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04134663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*